GB0919325D0 - 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic receptor modulators for treating neurologic disorders - Google Patents
1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic receptor modulators for treating neurologic disordersInfo
- Publication number
- GB0919325D0 GB0919325D0 GB0919325A GB0919325A GB0919325D0 GB 0919325 D0 GB0919325 D0 GB 0919325D0 GB 0919325 A GB0919325 A GB 0919325A GB 0919325 A GB0919325 A GB 0919325A GB 0919325 D0 GB0919325 D0 GB 0919325D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- azabicyclo
- substituted
- receptor modulators
- nicotinic receptor
- derivatives useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- -1 1-substituted 2-azabicyclo[3.1.1]heptyl Chemical class 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0919325A GB0919325D0 (en) | 2009-11-04 | 2009-11-04 | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic receptor modulators for treating neurologic disorders |
| EP10781853.6A EP2496579B1 (en) | 2009-11-04 | 2010-11-03 | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders |
| US13/504,618 US8809365B2 (en) | 2009-11-04 | 2010-11-03 | 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders |
| PCT/EP2010/066764 WO2011054885A1 (en) | 2009-11-04 | 2010-11-03 | 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0919325A GB0919325D0 (en) | 2009-11-04 | 2009-11-04 | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic receptor modulators for treating neurologic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0919325D0 true GB0919325D0 (en) | 2009-12-23 |
Family
ID=41501886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0919325A Ceased GB0919325D0 (en) | 2009-11-04 | 2009-11-04 | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic receptor modulators for treating neurologic disorders |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB0919325D0 (en) |
-
2009
- 2009-11-04 GB GB0919325A patent/GB0919325D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2310081B8 (en) | System for treating psychiatric disorders | |
| IL219914A (en) | 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | |
| ZA201001434B (en) | 2-aza-bicyclo[3.3.0]octane derivatives | |
| WO2009137843A9 (en) | Nmda receptor antagonists for the treatment of neuropsychiatric disorders | |
| IL204838A0 (en) | Tetrahydroquinoline derivatives for treating post - traumatic stress disorders | |
| IL208181A0 (en) | Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators | |
| IL212986A0 (en) | Methods for treating eye disorders | |
| GB0701042D0 (en) | Product authentication system | |
| ZA201000127B (en) | Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors | |
| EP2148856B8 (en) | Catalytic deamination for caprolactam production | |
| EP2311804A4 (en) | Method for preparing n-substituted maleimides | |
| IL202466A0 (en) | Process for preparing biaryls | |
| IL198004A0 (en) | Substituted imidazoles as bombesin receptor subtype-3 modulators | |
| IL196094A0 (en) | Cyclopropyl amine derivatives as histamin h3 receptor modulators | |
| PL1841433T3 (en) | Composition for treating central nervous system disorders | |
| EP2323989A4 (en) | Methods for making central nervous system agents that are trpv1 antagonists | |
| GB2469980A8 (en) | Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof. | |
| WO2010083240A9 (en) | Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds | |
| GB0919325D0 (en) | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic receptor modulators for treating neurologic disorders | |
| IL218322A0 (en) | Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2,1]hept-5-enes | |
| IL214916A0 (en) | Process for preparaing 2,2 difluoroethylamine derivatives by imine hydrogenation | |
| IL206346A0 (en) | Process for preparing tetrahydroquinoline derivatives | |
| HK1157774A (en) | Methods for making central nervous system agents that are trpv1 antagonists | |
| HK1155643A (en) | Nmda receptor antagonists for the treatment of neuropsychiatric disorders | |
| HK1158106A (en) | Methods for treating viral disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |